These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 12569369

  • 1. Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer.
    Tsai MS, Shamon-Taylor LA, Mehmi I, Tang CK, Lupu R.
    Oncogene; 2003 Feb 06; 22(5):761-8. PubMed ID: 12569369
    [Abstract] [Full Text] [Related]

  • 2. Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo.
    Atlas E, Cardillo M, Mehmi I, Zahedkargaran H, Tang C, Lupu R.
    Mol Cancer Res; 2003 Jan 06; 1(3):165-75. PubMed ID: 12556556
    [Abstract] [Full Text] [Related]

  • 3. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH, Lin CC, Lin JK, Chen WJ.
    J Agric Food Chem; 2007 Jun 27; 55(13):5030-7. PubMed ID: 17539658
    [Abstract] [Full Text] [Related]

  • 4. Blocking HER-2/HER-3 function with a dominant negative form of HER-3 in cells stimulated by heregulin and in breast cancer cells with HER-2 gene amplification.
    Ram TG, Schelling ME, Hosick HL.
    Cell Growth Differ; 2000 Mar 27; 11(3):173-83. PubMed ID: 10768865
    [Abstract] [Full Text] [Related]

  • 5. Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage.
    Menendez JA, Mehmi I, Lupu R.
    Int J Oncol; 2005 Mar 27; 26(3):649-59. PubMed ID: 15703820
    [Abstract] [Full Text] [Related]

  • 6. HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype.
    Liu WM, Guerra-Vladusic FK, Kurakata S, Lupu R, Kohwi-Shigematsu T.
    Cancer Res; 1999 Nov 15; 59(22):5695-703. PubMed ID: 10582687
    [Abstract] [Full Text] [Related]

  • 7. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
    Balañá ME, Lupu R, Labriola L, Charreau EH, Elizalde PV.
    Oncogene; 1999 Nov 04; 18(46):6370-9. PubMed ID: 10597237
    [Abstract] [Full Text] [Related]

  • 8. Expression of heregulin by mouse mammary tumor cells: role in activation of ErbB receptors.
    Schmitt M, Walker MP, Richards RG, Bocchinfuso WP, Fukuda T, Medina D, Kittrell FS, Korach KS, DiAugustine RP.
    Mol Carcinog; 2006 Jul 04; 45(7):490-505. PubMed ID: 16482517
    [Abstract] [Full Text] [Related]

  • 9. Transcriptional up-regulation of paxillin expression by heregulin in human breast cancer cells.
    Vadlamudi R, Adam L, Tseng B, Costa L, Kumar R.
    Cancer Res; 1999 Jun 15; 59(12):2843-6. PubMed ID: 10383144
    [Abstract] [Full Text] [Related]

  • 10. Induction or suppression of expression of cytochrome C oxidase subunit II by heregulin beta 1 in human mammary epithelial cells is dependent on the levels of ErbB2 expression.
    Sun Y, Lin H, Zhu Y, Ma C, Ye J, Luo J.
    J Cell Physiol; 2002 Aug 15; 192(2):225-33. PubMed ID: 12115729
    [Abstract] [Full Text] [Related]

  • 11. Herstatin inhibits heregulin-mediated breast cancer cell growth and overcomes tamoxifen resistance in breast cancer cells that overexpress HER-2.
    Jhabvala-Romero F, Evans A, Guo S, Denton M, Clinton GM.
    Oncogene; 2003 Nov 06; 22(50):8178-86. PubMed ID: 14603258
    [Abstract] [Full Text] [Related]

  • 12. A deletion mutant of heregulin increases the sensitivity of breast cancer cells to chemotherapy without promoting tumorigenicity.
    Atlas E, Bojanowski K, Mehmi I, Lupu R.
    Oncogene; 2003 May 29; 22(22):3441-51. PubMed ID: 12776196
    [Abstract] [Full Text] [Related]

  • 13. Src family kinases and HER2 interactions in human breast cancer cell growth and survival.
    Belsches-Jablonski AP, Biscardi JS, Peavy DR, Tice DA, Romney DA, Parsons SJ.
    Oncogene; 2001 Mar 22; 20(12):1465-75. PubMed ID: 11313890
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro.
    Ma C, Lin H, Leonard SS, Shi X, Ye J, Luo J.
    Oncogene; 2003 Aug 14; 22(34):5281-90. PubMed ID: 12917629
    [Abstract] [Full Text] [Related]

  • 15. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.
    Yang C, Klein EA, Assoian RK, Kazanietz MG.
    Biochem J; 2008 Feb 15; 410(1):167-75. PubMed ID: 17941827
    [Abstract] [Full Text] [Related]

  • 16. Up-regulation of alphavbeta3 integrin expression is a novel molecular response to chemotherapy-induced cell damage in a heregulin-dependent manner.
    Vellon L, Menendez JA, Liu H, Lupu R.
    Differentiation; 2007 Nov 15; 75(9):819-30. PubMed ID: 17999741
    [Abstract] [Full Text] [Related]

  • 17. Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells.
    Tang FY, Chiang EP, Sun YC.
    J Nutr Biochem; 2008 May 15; 19(5):287-94. PubMed ID: 17651959
    [Abstract] [Full Text] [Related]

  • 18. Heregulin induces expression, ATPase activity, and nuclear localization of G3BP, a Ras signaling component, in human breast tumors.
    Barnes CJ, Li F, Mandal M, Yang Z, Sahin AA, Kumar R.
    Cancer Res; 2002 Mar 01; 62(5):1251-5. PubMed ID: 11888885
    [Abstract] [Full Text] [Related]

  • 19. Ectopic expression of the ErbB-3 binding protein ebp1 inhibits growth and induces differentiation of human breast cancer cell lines.
    Lessor TJ, Yoo JY, Xia X, Woodford N, Hamburger AW.
    J Cell Physiol; 2000 Jun 01; 183(3):321-9. PubMed ID: 10797306
    [Abstract] [Full Text] [Related]

  • 20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 01; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.